Bias in Clinical Trials? Researchers investigated the issue of race and equality of access to clinical trials. The following table shows the population distribution and the numbers of participants in clinical trials involving lung cancer (based on data from “Participation in Cancer Clinical Trials,” by Murthy, Krumholz, and Gross, Journal of the American Medical Association, Vol. 291, No. 22). Use a 0.01 significance level to test the claim that the distribution of clinical trial participants fits well with the population distribution. Is there a race>ethnic group that appears to be very underrepresented?Race/ethnicityWhitenon-HispanicHispanicBlackAsian , Pacific IslanderAmerican Indian,Alaskan NativeDistribution of Population75.6%9.1%10.8%3.8% 0.7%Number in Lung Cancer Clinical Trials3855603165412

The given information presents data on the population distribution and the number of participants in clinical trials for lung cancer, specifically focusing on race and ethnicity. The table displays the distribution of the population and the corresponding numbers of participants in each racial/ethnic group.

To determine if there is bias in the clinical trials, we need to test the claim that the distribution of clinical trial participants aligns well with the population distribution. We will use a significance level of 0.01 for this test.

First, let's calculate the expected number of participants in each racial/ethnic group based on the population distribution. To do this, we multiply the population distribution percentages by the total number of participants in the clinical trials.

Expected number of White non-Hispanic participants: 0.756 * 3855 = 2916.18 Expected number of Hispanic participants: 0.091 * 3855 = 351.345 Expected number of Black participants: 0.108 * 3855 = 416.34 Expected number of Asian/Pacific Islander participants: 0.038 * 3855 = 146.49 Expected number of American Indian/Alaskan Native participants: 0.007 * 3855 = 26.985

Next, we can perform a chi-square goodness-of-fit test to determine if the observed numbers of participants significantly differ from the expected numbers. The chi-square test statistic is calculated using the formula:

χ² = Σ((Observed - Expected)² / Expected)

We can now calculate the chi-square test statistic using the observed and expected numbers of participants in each racial/ethnic group:

χ² = ((385 - 2916.18)² / 2916.18) + ((560 - 351.345)² / 351.345) + ((316 - 416.34)² / 416.34) + ((541 - 146.49)² / 146.49) + ((2 - 26.985)² / 26.985)

After calculating the above expression, we obtain the chi-square test statistic. We can then compare this value to the critical chi-square value at a significance level of 0.01 with (number of categories - 1) degrees of freedom. In this case, since we have 5 categories, the degrees of freedom will be 4.

If the calculated chi-square test statistic is greater than the critical chi-square value, we reject the null hypothesis and conclude that there is evidence of bias in the clinical trials. Conversely, if the calculated chi-square test statistic is less than or equal to the critical chi-square value, we fail to reject the null hypothesis and conclude that there is no evidence of bias.

Additionally, we can examine the differences between the observed and expected numbers of participants in each racial/ethnic group to identify any groups that appear to be underrepresented. By comparing the observed numbers to the expected numbers, we can determine if any racial/ethnic group has significantly fewer participants than expected.

Based on the calculations and analysis, we can determine if there is bias in the clinical trials and identify any race/ethnic group that appears to be very underrepresented.